Cynthia Strout
North Charleston, SCNPI 1578690194
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,891 of the $2,396 with a category attached, or 79.0%. Every reported general payment came from a single manufacturer, Merck.
Across 18 payments — averaging $133.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$2K
Across 3,681 payments — averaging $6268.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$9.4M
- Modernatx, Inc.$5.6M
- Emergent Biosolutions Inc.$2.6M
- Sanofi Pasteur Inc.$1.5M
- Pfizer$1M
- Merck$874K
- plus $2.1M from 18 others
What the payments were for
- Travel & lodging$1,89179%
- Food & beverage$50421%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 18 | $2,396 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- V114$1,088
- GARDASIL 9$625
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.